Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Open in API
Filings indexed 653 across all filing types
Latest filing 2013-06-26 Regulatory Filings
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
Karo Bio ANNOUNCES EXTENSION OF EXISTING COLLABORATION WITH PFIZER TO DISCOVER AND DEVELOP DRUGS FOR AUTOIMMUNE DISEASES
Regulatory Filings Classification · 99% confidence The document is a press release announcing the extension of a research collaboration between Karo Bio and Pfizer regarding drug discovery for autoimmune diseases. It details the terms, scientific background, and includes contact information and boilerplate company descriptions. This type of announcement, which details a significant business development (a partnership extension with financial implications), does not fit neatly into the specific financial reporting categories (like 10-K, ER, IR, DIV). It is a general corporate announcement regarding business operations and strategy. Since it is not a standard regulatory filing like a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ), and it is not a presentation (IP) or a transcript (CT), the most appropriate general category for significant, non-standard corporate news is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements.
2013-06-26 English
ÅRSSTÄMMA 2013 I KARO BIO AB
AGM Information Classification · 98% confidence The document is titled 'ÅRSSTÄMMA 2013 I KARO BIO AB' (Annual General Meeting 2013 in Karo Bio AB) and details the key decisions made at the meeting, such as approval of financial statements, election/re-election of board members, setting director fees, and authorizing the board regarding share issuance. These are typical outcomes and announcements following an Annual General Meeting (AGM). Although it is a summary press release, the core subject matter directly relates to the AGM proceedings and decisions, making 'AGM Information' (AGM-R) the most appropriate classification over a general 'Earnings Release' (ER) or 'Report Publication Announcement' (RPA). The document explicitly states the decisions made 'På dagens årsstämma' (At today's annual general meeting).
2013-05-07 Swedish
ANNUAL GENERAL MEETING 2013 IN KARO BIO AB
AGM Information Classification · 99% confidence The document explicitly states it contains resolutions passed at the 'ANNUAL GENERAL MEETING 2013 IN KARO BIO AB'. It details voting outcomes regarding financial statements, dividend decisions, board member elections/reelections, auditor appointment, remuneration guidelines, and authorization for future share issues related to financing. This content directly relates to the formal proceedings and outcomes of an AGM. Therefore, the appropriate classification is AGM Information (AGM-R). The document is not a mere announcement of an AGM (RPA) but the summary of the results/resolutions themselves.
2013-05-07 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2013 for Karo Bio AB. It contains comprehensive financial data, including income statements, cash flow, and balance sheet summaries, as well as detailed management commentary on business operations and project portfolios. It is not a mere announcement or certification, but the full quarterly financial report itself. Q1 2013
2013-05-07 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT JANUARY-MARCH 2013' and contains comprehensive financial data, including net sales, net loss, earnings per share, cash flow, and a summary of key financial data for the specified period. It also includes detailed management commentary and project portfolio updates. It is not a short announcement, but a full interim financial report. Q1 2013
2013-05-07 English
VALBEREDNINGENS FÖRSLAG INFÖR ÅRSSTÄMMAN 2013
AGM Information Classification · 98% confidence The document title is "VALBEREDNINGENS FÖRSLAG INFÖR ÅRSSTÄMMAN 2013" which translates to "Nomination Committee's Proposal for the Annual General Meeting 2013". The text details the nomination committee's proposals regarding the board of directors, chairman, auditor, and remuneration for the upcoming Annual General Meeting (Årsstämma). This content is directly related to the preparation and proposals for the AGM, which falls under the scope of AGM Information (AGM-R). It is not a transcript (CT), an earnings release (ER), or a full annual report (10-K).
2013-04-30 Swedish

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.